Dr. Kathryn Rexrode is the Chief Academic Officer at Brigham and Women’s Hospital (BWH), Chief of the Division of Women’s Health in the Department of Medicine at BWH, and a Professor of Medicine at Harvard Medical School. As Chief Academic Officer she supports and advances the research and educational missions of the hospital. Dr.… Continue reading Kathryn Rexrode
Dr. Giles Boland is President of the Brigham and Women’s Physicians Organizations (BWPO) and Executive Vice President of Mass General Brigham (MGB). He also assumed the role of President of Brigham and Women’s Hospital on March 5, 2024. He is a radiologist by training and the Philip H. Cook Distinguished Professor of Radiology at Harvard… Continue reading Giles W.L. Boland
Andrea Baccarelli, MD, PhD, is the Dean of the Faculty at the Harvard T.H. Chan School of Public Health. A distinguished scientist, Dr. Baccarelli investigates the molecular mechanisms by which a wide array of environmental exposures causes human disease. He was elected to the National Academy of Medicine for his pioneering work showing that social… Continue reading Andrea Baccarelli
Ambassador Roman Macaya is a Menschel Senior Leadership Fellow at the Harvard T.H. Chan School of Public Health. In May 2022 he concluded his term-limited mandate as Executive President and Chairman of the Board of the Caja Costarricense de Seguro Social (the Costa Rican Social Security). The “Caja” is an autonomous institution with a workforce… Continue reading Román F. Macaya
Kate Calvin is the Executive Dean for Administration, overseeing the offices of Financial Services, Human Resources, Information Technology, Operations and Sponsored Programs Administration. Before joining Harvard Chan School in July 2022, Kate was the Associate Vice President for Finance at Elizabethtown College, where she lead the finance, budget, accounts payable, accounts receivable, treasury management and risk… Continue reading Kate Calvin
Dr. John Maraganore served as the founding CEO and a Director of Alnylam from 2002 to 2021, where he built and led the company from early platform research on RNA interference through global approval and commercialization of the first four RNAi therapeutic medicines, ONPATTRO®, GIVLAARI®, OXLUMO®, and Leqvio®. At Alnylam, he also led the company’s… Continue reading John M. Maraganore
Karin S. Leschly, MD, FAAFP, serves as the Medical Director of Quality Improvement and Population Health at the East Boston Neighborhood Health Center, one of the largest federally qualified community health centers in the nation.
Elliot Cohen is the co-founder and Chief Product Officer of PillPack, which was acquired by Amazon in 2018. He is a senior lecturer at MIT’s Sloan School of Management and a Founder Partner at Founder Collective. Prior to co-founding PillPack, he founded and directed MIT’s Hacking Medicine program. Mr. Cohen graduated from UC Berkeley with… Continue reading Elliot Cohen
Peter Hecht, Ph.D has served as Ironwood’s CEO and a director since co‐founding the company in 1998. He started Ironwood because he was attracted to “the idea of working with a team of people who challenge, inspire and humble me,” and building an enduring organization dedicated to creating important medicines.
Gwill York, MBA, is a pioneering entrepreneur with 30 years of experience financing early-stage technology and healthcare companies. Gwill co-founded Lighthouse Capital Partners in 1994, a structured venture capital partnership based in Cambridge and Menlo Park. At Lighthouse, she led investments in companies such as Vertex Pharmaceuticals, Millennium Pharmaceuticals, Cascade Communications, Sirocco Systems, Speechworks, Storage… Continue reading Gwill York